Skip to evidence report

B.memory.activated: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 3,376 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for B.memory.activated
#Trait / studyIndividual trait IDMean IC score
1TCL1A levelsGCST9047081780.22
2FCRL1 levelsGCST9046920579.63
3PARP1/TCL1A ratioGCST9031560275.04
4FCRL2 levelsGCST9046920674.87
5CD22 levelsGCST9046861072.73
6IL5RA levelsGCST9046960070.51
7Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474669.45
8CD27/TNFRSF13B ratioGCST9031377767.47
9FCRL5/LY96 ratioGCST9031480366.83
10FCER2 levelsGCST9046919965.77
11Lymphoid neoplasms (P-cell phenocluster)GCST9062473763.59
12FCER2/TREML2 ratioGCST9031479262.99
13Systemic lupus erythematosusGCST9001186661.82
14Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST9066873561.44
15TNFRSF13B/TNFSF13B ratioGCST9031593361.16
16TNFSF13B levelsGCST9047092057.81
17CD27/TNFRSF9 ratioGCST9031377857.14
18JCHAIN levelsGCST9046966155.38
19TCL1A/TNFRSF13C ratioGCST9031591255.32
20SLAMF1 levelsGCST9027483554.49
21CD72 levelsGCST9046864654.36
22TNFRSF13C levelsGCST9047090652.46
23FCER2/FCRL1 ratioGCST9031478951.91
24Disorders of plasma protein metabolism (PheCode 270.3)GCST9047570950.49
25Paraproteinemia (PheCode 270.32)GCST9047571049.83
26TNFRSF13B levelsGCST9047090549.36
27FCRL5/TNFRSF13B ratioGCST9031480548.82
28Non-albumin protein levelsUKBB0000050348.26
29Pain in limbFING0000113848.11
30Multiple myelomaGCST9062474748.04
31TNFRSF13B/TNFRSF9 ratioGCST9031593245.33
32FCER2/TCL1A ratioGCST9031479043.61
33Monoclonal gammopathy of undetermined significanceGCST9062474542.43
34ALB/Globulin ratioUKBB0000002042.03
35CD22/TCL1A ratioGCST9031376041.85
36ZNRD2 levelsGCST9047110341.44
37N-delta-acetylornithine levelsGCST9020069140.57
38FCER2/TNFRSF9 ratioGCST9031479140.00
39CD5L levelsGCST9046864039.72
40IL18RAP levelsGCST9046956639.22
41FCRL2/TNFRSF13B ratioGCST9031480138.58
42CR2/TNFRSF13B ratioGCST9031422538.30
43FCRL1/TREML2 ratioGCST9031479738.25
44INPP5J levelsGCST9046961838.18
45FCRL1/TCL1A ratioGCST9031479538.09
46Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475037.96
47TNFRSF17 levelsGCST9047090837.29
48Blood cell traits latent factor 17 (white cell)GCST9055925937.26
49CD22/SEMA7A ratioGCST9031375937.15
50Physical activity (confirmatory factor analysis Factor 23)GCST9030935737.07
51Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST9066851835.99
52T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST9032082335.96
53TXNDC15 levelsGCST9047099035.54
54Bifidobacterium kashiwanohense abundance in stoolGCST9003222632.25
55FCRL1/TNFRSF13C ratioGCST9031479631.69
56Lymphoid neoplasms (B-cell phenocluster)GCST9062473631.43
57UGDH levelsGCST9047100631.41
58CD79B/TNFRSF13B ratioGCST9031390231.36
59CD27/NBL1 ratioGCST9031377430.84
60Other soft tissue disorders, not elsewhere classifiedFING0000109930.76
61Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474030.10
62IL5RA/TNFRSF13B ratioGCST9031516429.73
63SEPTIN3 levelsGCST9047057629.63
64MZB1/TNFRSF13B ratioGCST9031550929.56
65NINJ1 levelsGCST9047004929.30
66FCRL2/LY9 ratioGCST9031479928.95
67CD27 levelsGCST9046861528.83
68Rheumatoid arthritisGCST9001869028.55
69Lymphocyte countGCST00462728.29
70Urine X-24796 levels in chronic kidney diseaseGCST9026680028.05
71LILRB1 levelsGCST9046977627.97
72Primary biliary cholangitisGCST9006144027.94
73FCRL5/ICAM3 ratioGCST9031480227.88
74CD22/FCRL1 ratioGCST9031375727.18
75Occupational attainmentGCST9010225327.01
76Lymphocyte count | Blood countUKBB0000041126.78
77CR2 levelsGCST9046885226.74
78Moderate to vigorous physical activity durationGCST9006142226.08
79FCRL2/SEMA7A ratioGCST9031480025.98
80Colitis, primary sclerosing, strict definitionFING0000031325.98
81TP53BP1 levelsGCST9047093625.79
82BLNK levelsGCST9046844825.44
83Lymphocyte countGCST9000238825.40
84CD27/TGFBR2 ratioGCST9031377625.36
85Chronic lymphocytic leukemiaGCST9062473825.32
86TNFRSF13B/TNFRSF13C ratioGCST9031593124.63
87Idiopathic pulmonary fibrosisFING0000065924.60
88Time spend outdoors in summer | Sun exposureUKBB0000081724.57
89CALCOCO1/MAP3K5 ratioGCST9031360524.57
90Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064124.51
91CD79B/TNFRSF4 ratioGCST9031390324.50
92Sicca syndrome [Sjögren]FING0000130424.48
93TNFRSF13C/TNFSF13B ratioGCST9031593424.43
94DTI TBSS FA Sagittal stratum LGCST9038441124.37
95KIF22 levelsGCST9046968224.20
96Lymphocyte count (UKB data field 30120)GCST9046808224.13
97PLXNA4/USP8 ratioGCST9031569024.10
98ICAM3/TNFRSF13B ratioGCST9031512423.76
99CD22/FOLR2 ratioGCST9031375823.70
100MBL2 levelsGCST9046986823.45
101Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING0000120323.29
102Lymphocyte countGCST9000231723.23
103PEAR1/TREML2 ratioGCST9031564523.17
104Principal component-derived dietary pattern 42GCST9013304723.12
105S100A11/S100A12 ratioGCST9031579822.91
106Blood cell traits latent factor 23 (white cell)GCST9055926522.89
107Lymphocyte countGCST9000231622.86
108CD27/DLL1 ratioGCST9031377122.69
109TRAF3 levelsGCST9047095722.60
110CD83/IL12A_IL12B ratioGCST9031390522.52
111GART levelsGCST9046930322.46
112Kela-code for severe mental illnessFING0000070722.26
113MYCT1 levelsGCST9061804622.03
114T1 FreeSurfer DKT rh insula areaGCST9038431721.87
115Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions)FING0000010121.80
116Systemic lupus erythematosusGCST9001423821.74
117PDCD1/TNFRSF8 ratioGCST9031561021.57
118CRYBB2 levelsGCST9046887521.52
119Rheumatoid arthritisGCST9013222421.38
120Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222721.23
121UrticariaFING0000140821.10
122QPCT/RNASET2 ratioGCST9031575820.83
123IL2RA levelsGCST9046958520.71
124Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST9066850520.64
125ZNF830 levelsGCST9047110220.26
126Bread type - Wholemeal or wholegrain | DietUKBB0000010720.24
127CD22/FCER2 ratioGCST9031375620.16
128GZMA/IL12A_IL12B ratioGCST9031500920.01
129Left ventricular end systole inferior wall thicknessGCST9027850919.97
130ThalamNuclei rh volume MGNGCST9000273719.95
131wg rh intensity-contrast lingualGCST9000383919.89
132Lymphoid leukaemia (controls excluding all cancers)FING0000074119.65
133Fibrosis and cirrhosis of liverFING0000054319.63
134LY96 levelsGCST9046982319.61
135CD27/CD79B ratioGCST9031377019.59
136THY1 levelsGCST9047086119.39
137IL16 levelsGCST9046955719.36
138Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activityUKBB0000087519.22
139IGLC2 levelsGCST9046953619.15
140Primary biliary cholangitisGCST00312919.14
141FOLR2 levelsGCST9046926019.13
142Physical activity (Relative amplitude)GCST9006143218.91
143mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544418.81
144Sleep durationGCST00383918.79
145CRTAP levelsGCST9046887218.78
146Cereal type - Other (e.g. Cornflakes, Frosties) | DietUKBB0000012518.64
147DepressionFING0000039818.61
148FCER1A levelsGCST9046919818.31
149Influenza and pneumoniaFING0000067918.26
150F-meat liking (derived food-liking factor)GCST9009479918.13
151FCGR2A levelsGCST9046920018.07
152Sleep apneaGCST9047582418.07
153IDP T1 FAST ROIs L cerebellum VGCST9000256417.86
154PRCP levelsGCST9047031417.80
155mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047544817.80
156Total protein levelsGCST9001875617.78
157Myasthenia gravisGCST9043215617.73
158Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561317.69
159Bread type - White | DietUKBB0000010617.54
160Seropositive rheumatoid arthritis, wideFING0000129817.48
161FCRL5 levelsGCST9046920817.40
162Lifetime number of sexual partners | Sexual factorsUKBB0000040617.36
163Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST9066873917.31
164PGR levelsGCST9047022317.31
165Bell pepper likingGCST9009470317.26
166ELOA/POLR2F ratioGCST9031464317.23
167T1 CAT volume L LeftAccumbensGCST9038410817.20
168CD79B/CKAP4 ratioGCST9031389817.16
169Mother's age | Family historyUKBB0000048417.13
170CD79B/FCRL1 ratioGCST9031389917.12
171Medication use (immunosuppressants)GCST9001877117.11
172Lymphocyte countGCST9002598417.02
173Types of physical activity in last 4 weeks - Strenuous sports | Physical activityUKBB0000087416.98
174Bifidobacterium catenulatum abundance in stoolGCST9003222416.92
175Total protein levelsUKBB0000082616.83
176Cough on most days | Medical informationUKBB0000015316.78
177CD302/IL12A_IL12B ratioGCST9031380616.65
178ATP5IF1/LYN ratioGCST9031338916.55
179Secondary hypothyroidism (PheCode 244.1)GCST9047564916.54
180Enthesopathies of lower limb, excluding footFING0000050916.45
181Diseases of middle ear and mastoidFING0000042716.37
182EDA2R levelsGCST9046906716.34
183Fracture of radius and ulna (PheCode 803.2)GCST9047628016.34
184PCSK7 levelsGCST9047017616.22
185Wears glasses or contact lenses | EyesightUKBB0000090716.16
186aparc-Desikan lh thickness paracentralGCST9000346116.09
187CCL5/TACC3 ratioGCST9031370716.07
188BSG/IL12A_IL12B ratioGCST9031353216.00
189Right ventricular ejection fractionGCST9013459115.89
190Number of days/week walked 10+ minutes | Physical activityUKBB0000053515.88
191GFRA2/IL12A_IL12B ratioGCST9031492515.86
192IL12A_IL12B/LAG3 ratioGCST9031514715.86
193DEFA1_DEFA1B/LCN2 ratioGCST9031445415.83
194Leisure/social activities - Other group activity | Social supportUKBB0000040015.73
195CRTAM/LY9 ratioGCST9031427815.72
196Lymphoid neoplasmsGCST9062474315.71
197Multiple sclerosisGCST9047583315.70
198Mood [affective] disordersFING0000083615.64
199Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239615.63
200Experiencing mood swingsGCST00694415.50
201CD27/FCRL5 ratioGCST9031377215.50
202IDP dMRI ProbtrackX L1 cgc lGCST9000425015.46
203Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST9013297315.43
204wg rh intensity-contrast cuneusGCST9000383115.43
205Diacylglycerol_33:1_[M+H-H2O]1+ levelsGCST9006017315.42
206Total protein levelsGCST9046810515.35
207Unspecified dementiaFING0000140015.34
208Fed-up feelings | Mental healthUKBB0000024215.29
209T1 FreeSurfer aseg Right-PutamenGCST9038416315.24
210Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST9030279915.23
211Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)GCST9013298615.19
212Broad bean likingGCST9009471115.19
213Beetroot likingGCST9009470215.17
214CA1/CA3 ratioGCST9031357215.17
215AppendectomyFING0000010415.17
216Rheumatoid arthritisGCST00067915.08
217SLAMF1 levelsGCST9047064915.07
218Rheumatoid arthritisFING0000126715.00
219EPHB6/VWC2 ratioGCST9031468314.96
220Seropositive rheumatoid arthritis, strict definitionFING0000129714.89
221ADH4/SCLY ratioGCST9031319514.85
222Principal component-derived dietary pattern 28GCST9013303314.76
223AFP levelsGCST9046825014.74
224CDKN1A/TACC3 ratioGCST9031397514.73
225Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084914.72
226Qualifications - A levels/AS levels or equivalent | EducationUKBB0000072714.66
227Biological Sibling: Cancer, SkinGCST9047636914.62
228CDKN2D/TACC3 ratioGCST9031399214.57
229Age completed full time education | EducationUKBB0000001314.53
230SEPTIN8 levelsGCST9047057814.45
231Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST9047527514.43
232T1 CAT volume L LeftPutamenGCST9038410014.29
233Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST9004222614.25
234Cardiorespiratory fitness (vo2 max)GCST9009331714.20
235lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542614.13
236X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST9024361914.13
237Rheumatoid arthritisGCST9013222314.11
238Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066875813.96
239CD38/IL12A_IL12B ratioGCST9031380813.93
240CLPP/DECR1 ratioGCST9031413713.85
241CTSO levelsGCST9046891513.79
242Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848513.72
243wg rh intensity-contrast pericalcarineGCST9000384713.67
244Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB0000087213.57
245CEACAM8/MMP9 ratioGCST9031400213.55
246Diseases of white blood cells (PheCode 288)GCST9047581213.54
247Qualifications - O levels/GCSEs or equivalent | EducationUKBB0000073113.48
248Strenuous sports or other exercisesGCST00610013.43
249Skin and soft tissue infectionsGCST9001341113.35
250Bread type: White (UKB data field 1448_1)GCST9013296413.29
251C2 levelsGCST9046849713.28
252SPINT1/SUSD2 ratioGCST9031587813.25
253Qualifications - None of the above | EducationUKBB0000072913.25
254rfMRI connectivity (ICA25 edge 103)GCST9000474613.24
255PDGFRB levelsGCST9047019213.21
256CD48 levelsGCST9042567613.19
257Loneliness, isolation | Mental healthUKBB0000040813.17
258Handedness (confirmatory factor analysis Factor 36)GCST9030937013.15
259Eosinophill count | Blood countUKBB0000020613.10
260CD74 levelsGCST9046864713.05
261IDP T1 FAST ROIs V cerebellum XGCST9000258813.04
262Eosinophill percentage | Blood countUKBB0000020713.03
263NUBP1 levelsGCST9047010013.00
264Qualifications - Other professional qualifications eg: nursing, teaching | EducationUKBB0000073212.99
265Disorders of orbitFING0000044912.98
266Syncope and collapse | symptomsUKBB0000080112.95
267LRRC37A2 levelsGCST9046980212.91
268WASL levelsGCST9047107012.90
269Red meat likingGCST9009481912.81
270Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051812.78
271IPCEF1/TBCC ratioGCST9031518812.78
272Aniseed likingGCST9009468912.78
273Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)GCST9013296712.76
274Mood swings | Mental healthUKBB0000048212.75
275CHIT1 levelsGCST9046874412.71
276Crisps likingGCST9009474712.70
277Alcohol drinker status - Current | AlcoholUKBB0000002112.67
278Use of dietary supplements (confirmatory factor analysis Factor 13)GCST9030934712.59
279T1 CAT GM unnormalised volumeGCST9038398212.54
280LILRB2 levelsGCST9046977712.50
2813,5-dichloro-2,6-dihydroxybenzoic acid levelsGCST9020025212.45
282CD84/TREML2 ratioGCST9031391912.37
283CD79B levelsGCST9046864812.36
284X-11444 metabolite levelGCST9061654512.34
285CHI3L1/PRSS8 ratioGCST9031404412.33
286Hypercalcemia (PheCode 275.6)GCST9047574812.33
287C9 Carnitine levels in chronic kidney diseaseGCST9025768212.33
288Lamb or mutton consumption (UKB data field 1379)GCST9013299812.23
289CD20 on IgD- CD24- B cellGCST9000175312.22
290Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086012.22
291F-cooking flavour liking (derived food-liking factor)GCST9009474212.11
292Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING0000024012.09
293Irritable bowel syndromeGCST9001656412.06
294C1QTNF1/COL18A1 ratioGCST9031355112.06
295Plasma argininate* levels in chronic kidney diseaseGCST9026482612.05
296Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075612.03
297ADGRE2 levelsGCST9046823711.96
298Tyrosine levelsGCST9020042711.96
299LTA levelsGCST9046981311.92
300EFNA4/VWC2 ratioGCST9031460711.91
301Eosinophil percentage of white cellsGCST9000238211.89
302CRTAM/ICAM3 ratioGCST9031427611.82
303aparc-DKTatlas lh thickness paracentralGCST9000355511.78
304CFHR2 levelsGCST9046872611.78
305Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers)FING0000084311.78
306PDCD1/TNFRSF9 ratioGCST9031561111.74
307Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST9047601411.73
308Blood cell traits latent factor 12 (red cell)GCST9055925411.73
309Eosinophil countGCST9000238111.70
310Moderate-to-vigorous intensity physical activity during leisure timeGCST9010434111.70
311lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542911.66
312Thyroid problemsGCST9047527611.64
313Use of hypnotics and sedativesFING0000141111.60
314Osteoarthrosis (PheCode 740)GCST9047625311.58
315Salty food likingGCST9009482811.58
316IL22 levelsGCST9046958211.58
317CD5/TNFRSF9 ratioGCST9031386211.57
318NFATC3 levelsGCST9047003411.56
319HNRNPK/USP8 ratioGCST9031507011.55
320Lymphocyte countGCST9001874211.54
321T1 CAT volume R RightThalamusGCST9038409711.54
322Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253511.51
323Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activityUKBB0000087011.50
324TYRP1 levelsGCST9047099811.45
325MGAT2 levelsGCST9008956011.43
326SORT1/ST6GAL1 ratioGCST9031586911.42
327Right ventricular ejection fraction (MTAG)GCST9013459511.41
328Neurofibromatosis, type 2FING0000086711.35
329TNFRSF11A levelsGCST9027764411.35
330CD160/NCR1 ratioGCST9031373211.31
331Liver likingGCST9009479411.31
332Use of disulfiram, acamprosate or naltrexoneFING0000141011.28
333Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING0000084611.26
334Hypothyroidism, drug reimbursementFING0000065511.25
335Omega-3 fatty acids to total fatty acids percentageGCST9050244811.24
336lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542311.20
337Time spent driving | Physical activityUKBB0000081811.17
338Eosinophil countGCST00460611.15
339Left ventricular end systole inferoseptal wall thicknessGCST9027850811.14
340Primary biliary cholangitis (PBC)FING0000121111.14
341Benign neoplasm of other and unspecified endocrine glandsFING0000015911.13
342Seminoma of testis, excluding all cancers (controls excluding all cancers)FING0000128911.13
343Eosinophill percentage (UKB data field 30210)GCST9046806911.09
344ZP3 levelsGCST9047110511.06
345Eosinophil countGCST9002598711.06
346MAP3K5/MAVS ratioGCST9031537911.04
347RCC1 levelsGCST9047044311.00
348DAB2/FKBP1B ratioGCST9031436210.99
349CCL5/SELP ratioGCST9031370510.98
350PECAM1/SOD2 ratioGCST9031564710.98
351Physical activity (Total log acceleration 10pm-12am)GCST9006142010.96
352Prescriptions - thyroid hormone | hormoneUKBB0000070510.96
353Prescriptions - levothyroxine | thyroid hormoneUKBB0000068710.96
354Mineral and other dietary supplements - None of the above | MedicationUKBB0000047410.93
355CD20 on IgD- CD27- B cellGCST9000175410.93
356PADI2 levelsGCST9047014210.89
357Eosinophil percentage of white cellsGCST00460010.88
358F-sauces liking (derived food-liking factor)GCST9009483110.87
359CLEC4G levelsGCST9046877410.75
360Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066852410.70
361Eosinophil countGCST9000229810.67
362Age when finished full-time education (standard GWA)GCST9026728010.58
363TNFRSF8/TNFRSF9 ratioGCST9031594010.55
364T1 FreeSurfer aseg Right-CaudateGCST9038416210.52
365LSP1 levelsGCST9046981110.47
366IBD (strict) with PSCFING0000065710.46
367IDP T1 FAST ROIs L cerebellum XGCST9000258710.46
368Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB0000046110.45
369AIDA levelsGCST9046826510.44
370GZMA/LTA ratioGCST9031501210.41
371aparc-a2009s rh thickness G-temporal-middleGCST9000371410.39
372FAS levelsGCST9046919210.37
373C1R levelsGCST9046849310.37
374PIKFYVE levelsGCST9047023510.36
375DTI TBSS L2 Sagittal stratum LGCST9038450710.32
376Thyrotoxicosis with diffuse goitreFING0000136110.31
377T1 FreeSurfer aseg rhCerebralWhiteMatterVolGCST9038418610.30
378HypothyroidismGCST9046813810.30
379Eosinophill count (UKB data field 30150)GCST9046806810.29
380Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activityUKBB0000087310.29
381Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary OperationsUKBB0000057510.27
382Other and unspecified tonsillitisFING0000095410.22
383Active to sedentary transition probabilityGCST9006142910.20
384PRTG levelsGCST9047034710.20
385SKAP1 levelsGCST9047064510.19
386HippSubfield rh volume subiculum-bodyGCST9000269110.18
387SLAMF7 levelsGCST9047065110.16
388LYN/TACC3 ratioGCST9031535010.11
389Ulcerative colitisGCST9001871310.10
390POMC levelsGCST9047028410.07
391Participation in an health questionnaire (not invited vs invited)GCST9001279410.07
392T1 CAT volume R RightPutamenGCST9038410110.06
393MMP1/SERPINB6 ratioGCST9031546210.03
394Clonal haematopoiesis of indeterminate potential (TET2 mutation)GCST9016528110.00
395SSC-A on plasmacytoid Dendritic CellGCST900020729.98
396TOP1 levelsGCST904709339.97
397CD27/NECTIN4 ratioGCST903137759.97
398Takes medication for Thyroid problems?GCST904752779.95
399TCN2 levelsGCST904708209.95
400Allergy/adverse effect of penicillin | injuries & poisoningsUKBB000000289.93
401IDP T1 FAST ROIs L postcent gyrusGCST900024839.92
402CRTAM levelsGCST904688719.91
403LGALS8/SOD2 ratioGCST903153209.91
404Acceptance of an invitation to participate in a mental health questionnaireGCST900127929.86
405Principal component-derived dietary pattern 9GCST901330149.81
406Thyroid peroxidase antibody levels in pregnancyGCST904352019.80
407Subjective well-beingGCST901048979.79
408Mean reticulocyte volumeGCST900259759.77
409GABBR2 levelsGCST902412309.77
410SERPINA9 levelsGCST904705889.76
411F-fruit liking (derived food-liking factor)GCST900947679.76
4121,5-anhydroglucitol (1,5-ag) levelsGCST902435299.75
413ENPP5 levelsGCST904691169.71
414Substance use, excluding alcoholFING000013429.71
415GFRA2 levelsGCST904693299.70
416Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental healthUKBB000003389.66
417KDM3A levelsGCST904696719.65
418ChalazionFING000002679.65
419ARHGAP30 levelsGCST904683549.61
420CABP2 levelsGCST904685199.61
421CD22/CD79B ratioGCST903137559.59
422CAPN3 levelsGCST904685389.53
423MAPRE3 levelsGCST904698599.51
424Salami likingGCST900948259.51
425Usual side of head for mobile phone use - Left | Electronic device useUKBB000008899.50
426Job involves mainly walking or standing | EmploymentUKBB000003849.49
427REST UKBBICA NODEamps25 0003GCST903854869.47
428Age when finished full-time education (weighted GWA)GCST902672819.47
429IL2RB levelsGCST904695869.44
430Thyroid peroxidase antibody positivity in pregnancyGCST904352029.43
431Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1)GCST901329749.43
432Other hypothyroidism | Disorders of thyroid glandUKBB000006119.43
433Mean sphered cell volume (UKB data field 30270)GCST904680899.41
434IL12A or IL12B levelsGCST904695489.40
435CLEC4C levelsGCST904687729.39
436T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903206239.39
437Nerve, nerve root and plexus disordersFING000008629.39
438S100P levelsGCST904705209.39
439Eosinophil percentage of granulocytesGCST0046179.39
440REG3A levelsGCST904704499.37
441PPP1R2/TACC3 ratioGCST903157199.36
442EZR levelsGCST904691629.35
443Psoriasis vulgarisGCST900186879.33
444TACC3/TBC1D23 ratioGCST903159009.29
445THBS2 levelsGCST904708549.29
446Spleen volumeGCST900166679.29
447CXCL5/PLXNA4 ratioGCST903143519.27
448Hypothyroidism NOS | endocrine/metabolicUKBB000003369.26
449Sum eosinophil basophil countsGCST0046249.24
450Mineral and other dietary supplements - Calcium | MedicationUKBB000004719.23
451Principal component-derived dietary pattern 16GCST901330219.22
452Prescriptions - antispasmodicUKBB000006669.21
453Lamb likingGCST900947909.20
454EFNA4/TNFRSF9 ratioGCST903146069.20
455MMP8/OLR1 ratioGCST903154649.19
4562,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levelsGCST902002339.19
457CXCL11 levelsGCST902747819.19
458Soft tissue disordersFING000013169.17
459Osteoarthritis, localized (PheCode 740.1)GCST904762549.15
460T1 CAT volume R TemporalFusiformCortexposteriordivisionGCST903840759.13
461All pneumoniaeFING000000659.12
462PDCD6IP levelsGCST906189699.11
463Vitamin and mineral supplements - None of the above | MedicationUKBB000009019.10
464T1 CAT volume R RightAccumbensGCST903841099.10
465rfMRI amplitudes (ICA100 node 27)GCST900046159.09
466ATOX1/TMSB10 ratioGCST903133779.04
467SIT1 levelsGCST904706449.03
468Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329689.03
469IDP T1 FAST ROIs R cerebellum VGCST900025658.99
470CDHR1 levelsGCST904686788.95
471CD244/CRTAM ratioGCST903137638.94
472Cereal type - Oat cereal (e.g. Ready Brek, porridge) | DietUKBB000001248.92
473Hypothyroidism | endocrine/metabolicUKBB000003358.91
474CD20 on IgD- CD38- B cellGCST900017558.90
475CD58/MEGF10 ratioGCST903138538.89
476PLXNB2/SEMA7A ratioGCST903156928.87
477RTBDN levelsGCST904705058.86
478MCTS1 levelsGCST904698748.84
479ERBB4/F3 ratioGCST903146908.83
480ROR1/TNFRSF21 ratioGCST903157878.82
481Loneliness (standard GWA)GCST902672888.82
482SNX2 levelsGCST904707018.80
483ThyrotoxicosisFING000013608.79
484Diseases of the digestive systemFING000004298.79
485CEP85/ZBTB16 ratioGCST903140268.78
486X-11787 levelsGCST902004658.78
487DCTN6/TDRKH ratioGCST903144368.77
488CNTNAP2 levelsGCST904688088.74
489CCL3 levelsGCST900120558.74
490Sphingomyelin_33:1_[M+H]1+ levelsGCST900602298.73
491High myopiaGCST0099628.73
492DTI autoptx FA ifo l tractGCST903851248.70
493Suicide or other Intentional self-harmFING000013458.69
494Wears glasses or contact lenses (UKB data field 2207)GCST900428758.69
495Triacylglycerol_51:2_[M+NH4]1+ levelsGCST900604978.69
496CRTAM/TNFRSF9 ratioGCST903142808.65
497ARTN levelsGCST904683728.64
498Mean sphered cell volume | Blood countUKBB000004528.63
499Risk taking | Mental healthUKBB000007598.62
500Neutrophil percentage of granulocytesGCST0046238.61
501Pure hyperglyceridaemiaFING000012318.60
502Ulcerative colitisGCST0041338.60
503ANPEP/CXADR ratioGCST903132728.57
504Lysoalkenylphosphatidylethanolamine (P-20:0) levelsGCST900254608.57
505Operation code - tonsillectomy +/- adenoids | OperationsUKBB000005678.55
506CA3/HMBS ratioGCST903135848.54
507Ceramide (d16:1/22:0) levelsGCST900240268.52
508DTI TBSS L1 Cingulum cingulate gyrus LGCST903844638.50
509ITGAL levelsGCST904696378.50
510DTI TBSS FA Posterior thalamic radiation RGCST903844088.49
511Hereditary hemolytic anemias (PheCode 282)GCST904757798.47
512Physical activityGCST900933228.47
513Shoulder lesionsFING000013038.45
514PFKFB2/SRP14 ratioGCST903156508.45
515IL12B levelsGCST904695498.45
516Graves' diseaseGCST900186278.41
517Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329668.39
518CD48/CRTAM ratioGCST903138398.37
519TNFRSF6B levelsGCST904709148.36
520Beef/steak likingGCST900947008.36
521Autoimmune diseasesFING000001318.33
5221-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996528.32
523ADM levelsGCST900119968.31
524DTI autoptx FA ifo r tractGCST903851258.28
525Left ventricular end systole anterolateral wall thicknessGCST902785118.27
526Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276ECGU0002768.27
527aparc-DKTatlas rh thickness lingualGCST900035828.26
528CD244/TREML2 ratioGCST903137678.25
529Triacylglycerol_52:2_[M+NH4]1+ levelsGCST900605118.24
530CD40/TNFRSF14 ratioGCST903138308.22
531Hypothyroidism, strict autoimmuneFING000006568.21
532FCRL3 levelsGCST904692078.20
533Pain in joint (PheCode 745)GCST904762628.20
534Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST903093698.19
535TDRKH/TST ratioGCST903159138.18
536Early-onset myasthenia gravisGCST900934658.17
537Lichen sclerosus et atrophicusFING000007238.16
538GDNF levelsGCST902747928.16
539Comfortable retirement (confirmatory factor analysis Factor 29)GCST903093638.11
540Usual side of head for mobile phone use - Right | Electronic device useUKBB000008908.08
541LGALS4 levelsGCST904697628.07
542F-strong flavour liking (derived food-liking factor)GCST900948518.07
543Number of incorrect matches in round | Pairs matchingUKBB000005388.03
544PLAUR levelsGCST900120518.00
545F9/FURIN ratioGCST903147477.97
546LTA/LTBR ratioGCST903153367.97
547Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemiaGCST906247447.96
548INSR levelsGCST904696237.96
549Other and/or unspecified nontoxic goitreFING000009587.96
550Educational attainmentGCST0034967.89
551PFKM levelsGCST906188027.89
552Triacylglycerol_53:2_[M+NH4]1+ levelsGCST900605317.88
553TNFRSF4/TNFRSF8 ratioGCST903159387.88
554ITGB7 levelsGCST904696477.87
555IDP dMRI ProbtrackX FA fmaGCST900039357.87
556Polyglandular dysfunctionFING000011867.85
557wg lh intensity-contrast caudalmiddlefrontalGCST900037957.85
558Operation code - wisdom teeth surgery | OperationsUKBB000005697.84
559eosinophil (fraction, mean, inv-norm transformed)GCST904753007.83
560Corneal edema (PheCode 364.2)GCST904758627.80
561ITGB1BP2/PTPN6 ratioGCST903152187.80
562Treatment/medication code - lansoprazole | MedicationsUKBB000008487.78
563CD163 levelsGCST904686007.78
564mean corpuscular volume (MCV, mean, inv-norm transformed)GCST904754707.76
565aseg lh intensity Cerebellum-CortexGCST900037677.75
566SEMA4C levelsGCST904705727.74
567Skin color (cheek, ITA value)GCST905027807.74
568Disorders of the thyroid glandFING000004637.73
569Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB000006587.73
570Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB000006707.73
571Osteoarthrosis NOS (PheCode 740.9)GCST904762567.73
572Postinflammatory pulmonary fibrosis (PheCode 502)GCST904760327.71
573NOTCH1/SEMA7A ratioGCST903155457.70
574mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST904754667.69
575Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3)GCST900418037.69
576Cervicobrachial syndromeFING000002667.63
577Current employment status - Retired | EmploymentUKBB000001597.62
578TSC1 levelsGCST904709727.61
579Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST904762897.61
580HypothyroidismGCST903193207.59
581RAP1A levelsGCST904704257.59
582BMP7 levelsGCST900881577.59
583Omega-3 fatty acid levelsGCST905024227.58
5841-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST902000757.57
585Thyroid cancer (PheCode 193)GCST904756007.57
586Chronic obstructive pulmonary disease in current smokersGCST900165937.54
587Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002297.52
588Mean corpuscular hemoglobin concentrationGCST900187457.51
589Strawberries likingGCST900948497.50
590Lichen ruber planus, wide definition including periferal and oral lichen planusFING000007227.48
591IDP dMRI ProbtrackX OD str lGCST900044737.45
592Cervical cancerGCST900185977.45
593HypothyroidismGCST902041677.45
594Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB000003027.44
595DRAXIN levelsGCST904690387.41
596ICAM3/LY9 ratioGCST903151217.41
597Mosaic chromosomal alteration of the X chromosomeGCST901652877.40
598mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST904754747.39
599QPCT levelsGCST904704017.38
600CCDC50 levelsGCST904685617.36
601Estradiol levelsGCST900121057.35
602GZMB levelsGCST904694247.33
603Physical activityGCST900933237.33
604CASP8/PPP3R1 ratioGCST903136547.32
605Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762027.30
606Respiratory disease (confirmatory factor analysis Factor 11)GCST903093457.29
607PDZK1 levelsGCST904702037.29
608IDP dMRI ProbtrackX L3 ptr rGCST900043207.28
609Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003037.27
610CD209/CLEC14A ratioGCST903137497.25
611Alcohol usually taken with meals (UKB data field 1618)GCST901330047.24
612DTI TBSS L3 Sagittal stratum LGCST903845557.24
613Obstructive sleep apnea (PheCode 327.32)GCST904758257.22
614TNFRSF14/TNFSF14 ratioGCST903159367.21
615CD164/CD99 ratioGCST903137407.19
616Light-intensity physical activity durationGCST900614217.19
617CD6 levelsGCST904686447.19
618Triacylglycerol_50:2_[M+NH4]1+ levelsGCST900604737.18
619Poisoning by antibiotics | injuries & poisoningsUKBB000006537.17
620Ulcerative colitis (strict) with PSCFING000013897.16
621Current employment status - In paid employment or self-employed | EmploymentUKBB000001587.14
622Physical activity (Total log acceleration)GCST900614087.14
623Morning/evening person (chronotype) | SleepUKBB000004837.12
624APBB1IP/POLR2F ratioGCST903133007.12
625CD163/MARCO ratioGCST903137377.12
626ADM levelsGCST904682467.12
627CD101 levelsGCST904685967.12
628LCN2/PRTN3 ratioGCST903153077.11
629Urine N1,N12-diacetylspermine levels in chronic kidney diseaseGCST902656837.10
630Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685267.10
631HippSubfield rh volume presubiculum-headGCST900026957.09
632ST13 levelsGCST904707517.09
633Mean spheric corpuscular volumeGCST900023977.08
634Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)GCST0036587.08
635DTI autoptx FA ilf r tractGCST903851277.08
636wg lh intensity-contrast cuneusGCST900037967.08
637Ceramide (d18:2/22:0) levelsGCST900246827.07
638Triacylglycerol_52:1_[M+NH4]1+ levelsGCST900605157.07
639Asthma (adult onset)GCST0077997.06
640CEACAM8/PGLYRP1 ratioGCST903140037.05
641Allergic conjunctivitisFING000000677.04
642Spherical power (right) | AutorefractionUKBB000007917.03
643Red cell distribution width varianceGCST905657057.03
644Time to complete round | Pairs matchingUKBB000008227.03
645SNX15 levelsGCST904706997.02
646Triacylglycerol_50:3_[M+NH4]1+ levelsGCST900604687.02
647Asthma (childhood onset)GCST0078007.02
648Brussel sprout likingGCST900947147.01
649Number of non-cancer illnesses (standard GWA)GCST902672907.01
650Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027327.00
651HippSubfield rh volume subiculum-headGCST900026937.00
652F-highly palatable foods liking (derived food-liking factor)GCST900947856.99
653NME3 levelsGCST904700556.98
654ADD1 levelsGCST904682336.97
655Gastroesophageal reflux diseaseGCST900005146.97
656SDK2 levelsGCST904705626.96
657IDP dMRI TBSS FA Retrolenticular part of internal capsule LGCST900038986.94
658MMP1 levelsGCST904699196.93
659Coeliac diseaseFING000003126.93
6605alpha-androstan-3alpha,17beta-diol monosulfate (1) levelsGCST901998586.91
661Repeated disturbing thoughts of stressful experience in past month | Traumatic eventsUKBB000007506.90
662MS-disease / Multiple SclerosisFING000008396.88
663Cardiorespiratory fitness (vo2 max)GCST900933166.87
664Principal component-derived dietary pattern 12GCST901330176.87
665Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)GCST900276386.86
666HDAC8 levelsGCST904694386.84
667Soy sauce likingGCST900948446.83
668PPP1R2/USP8 ratioGCST903157236.83
669Schizophrenia or delusion (more control exclusions)FING000012786.82
670Number of sexual partners in opposite-sex sexual behaviorGCST900264816.81
671CCL3 levelsGCST904685826.81
672How are people in household related to participant - Husband, wife or partner | HouseholdUKBB000003306.80
673Burger likingGCST900947156.80
674Feeling fed-upGCST0069476.79
675IDP T1 FAST ROIs L cerebellum VIIbGCST900025756.79
676GALNT5 levelsGCST904692986.78
677Triacylglycerol_48:3_[M+NH4]1+ levelsGCST900604186.78
678Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000156.77
679Any mental disorderFING000001006.77
680ADGRE5/VCAM1 ratioGCST903131846.76
681Nephrotic syndromeGCST900186646.75
682aparc-Desikan rh thickness lingualGCST900034916.75
683MAMDC4 levelsGCST904698426.75
684CD48/SLAMF7 ratioGCST903138426.75
685Left-hemisphere control network to amygdala white-matter structural connectivityGCST903027576.73
686Osteoarthrosis, localized, primary (PheCode 740.11)GCST904762556.72
687Vitamin D levelsGCST0053676.72
688Number of vehicles in household | HouseholdUKBB000005436.72
689Carnitine levelsGCST901996216.70
690DAPP1/ITGB1BP2 ratioGCST903143886.68
691LAYN/VWC2 ratioGCST903152936.68
692AV-blockFING000001376.68
693T1 FreeSurfer aseg Left-Inf-Lat-VentGCST903841406.68
694ITGB1/ITGB2 ratioGCST903152256.67
695Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277ECGU0002776.65
696Lymphocyte percentage of white cellsGCST900023896.65
697IDP T1 FAST ROIs L subcallosal cortexGCST900025036.63
698ARNT levelsGCST904683676.61
699LCN2/PGLYRP1 ratioGCST903153066.61
700ADGRE5/SEMA7A ratioGCST903131836.60
701Triacylglycerol_50:4_[M+NH4]1+ levelsGCST900604666.59
702Aplastic anemia (PheCode 284)GCST904757836.59
703CCL17/PDGFB ratioGCST903136886.58
704HAVCR2 levelsGCST904215156.58
705Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005136.56
706S100A14 levelsGCST904705156.55
707wg lh intensity-contrast rostralmiddlefrontalGCST900038186.55
708Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523FING000003046.54
709CD160 levelsGCST904685996.54
710Left ventricular end systole inferolateral wall thicknessGCST902785106.54
711FUT8/TNFSF14 ratioGCST903148956.53
712Breast cancerGCST904298466.53
713Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB000003396.52
714Cardiorespiratory fitness slopeGCST900933206.52
715F-dessert liking (derived food-liking factor)GCST900947546.52
716GALNT10/SEMA7A ratioGCST903149156.52
717Reimbursement for rheumatic diseasesFING000012476.52
718Principal component-derived dietary pattern 8GCST901330136.51
719Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002666.50
720ICAM3 levelsGCST904695006.50
721LAIR1 levelsGCST904697286.50
722Uterine fibroidsGCST904681546.49
723Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB000005066.49
724Educational attainmentGCST0025986.48
725Cucumber likingGCST900947496.48
726Duration walking for pleasure | Physical activityUKBB000002036.48
727F-cooking vegetables liking (derived food-liking factor)GCST900947436.48
728Ceramide (d17:1/24:0) levelsGCST900240336.47
729T1 FreeSurfer aseg Right-choroid-plexusGCST903841706.47
730Seen doctor (GP) for nerves, anxiety, tension or depression | Mental healthUKBB000007656.47
731ICD10 O13: Gestational hypertensionGCST904542326.46
732AsthmaGCST0100426.45
733ADGRE1 levelsGCST904682366.45
734eosinophil (fraction, maximum, inv-norm transformed)GCST904752976.44
735Raynauds phenomenon diseaseGCST902717136.44
736PLXNB2 levelsGCST904702666.43
737Body-mass index, inverse-rank normalizedFING000002226.43
738LGALS4/PCDH17 ratioGCST903153156.42
739Other diseases of upper respiratory tractFING000010126.42
740neutrophil (fraction, mean, inv-norm transformed)GCST904755386.40
741Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618)GCST901329256.39
742B2M levelsGCST904684096.38
743CALCOCO1/CRACR2A ratioGCST903135986.37
744STC1 levelsGCST904707616.35
745Plasma succinylcarnitine (C4-DC) levels in chronic kidney diseaseGCST902659986.35
746Psoriasis vulgaris (PheCode 696.41)GCST904761906.35
747Diseases of external earFING000004246.35
748CD163/ICAM1 ratioGCST903137356.34
749BLMH/PEAR1 ratioGCST903135196.33
750Psoriasis (PheCode 696.4)GCST904761876.33
751CEP43/MPHOSPH8 ratioGCST903140196.32
752Impacted cerumen (PheCode 380.4)GCST904759016.32
7535,6-dihydrouridine levelsGCST901997676.32
754CLEC4G/MERTK ratioGCST903141216.31
755Apples likingGCST900946916.31
756Anxiety disorders (more control exclusions)FING000000986.31
757Lymphocyte percentage (UKB data field 30180)GCST904680836.30
758MDGA1 levelsGCST904698756.30
759IFI30 levelsGCST904695096.30
760PGLYRP1 levelsGCST904702196.28
761SUSD2 levelsGCST904707876.28
762rfMRI connectivity (ICA100 edge 495)GCST900053486.28
763Follicular lymphoma, hilmo (controls excluding all cancers)FING000005486.27
764CRTAM/VCAM1 ratioGCST903142816.26
765IDO1 levelsGCST904695066.23
766Neutrophil percentage of white cellsGCST900023996.23
767Graves disease, strict definitionFING000005926.23
768Osteochondrodysplasia with defects of growth of tubular bones and spineFING000009106.22
769IDP dMRI TBSS FA Posterior thalamic radiation LGCST900039066.20
770DTI TBSS L2 Posterior thalamic radiation RGCST903845046.20
771Mean reticulocyte volume | Blood countUKBB000004516.18
772Family relationship satisfaction | Mental healthUKBB000002386.18
773Spinal stenosis | musculoskeletalUKBB000007926.17
774FAM151A levelsGCST902424506.16
775Asthma and allergyFING000001156.15
776F-vegetarian liking (derived food-liking factor)GCST900948636.15
777Pregnancy with abortive outcomeFING000012056.14
778L1CAM levelsGCST904697236.13
779ADM/CLMP ratioGCST903131976.12
780Types of transport used (excluding work) - Public transport | Physical activityUKBB000008786.12
781CEP43/USP8 ratioGCST903140226.12
782Blood cell traits latent factor 9 (white cell)GCST905592516.12
783CRTAM/PDCD1 ratioGCST903142796.11
784IL7R levelsGCST904696056.11
785PADI4 levelsGCST904701436.10
786SEMA7A levelsGCST904705756.10
787DTI TBSS L3 Posterior thalamic radiation RGCST903845526.09
788Feeling lonelyGCST0069426.08
789S100A11/SERPINB8 ratioGCST903157996.08
790CRISP2 levelsGCST904688656.08
791BAG6/BMP6 ratioGCST903134506.07
792Psoriasis (vulgaris), strict definitionFING000012236.05
793EIF3J levelsGCST902411226.04
794TNFRSF9 levelsGCST904709166.04
795wg rh intensity-contrast lateraloccipitalGCST900038376.02
796CA1/HMBS ratioGCST903135736.01
797FAM3B/GPA33 ratioGCST903147785.99
798Ventricular arrhythmiaGCST900187205.99
799Red wine consumption (glasses per month) (UKB data field 1578, 4419)GCST901329875.96
800Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000985.96
801Right-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903028345.96
802Inflammatory bowel disease, strict (require KELA)FING000006755.95
803Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB000001015.95
804Age at first sexual intercourseGCST900000455.94
805Emotionally unstable personality disorderFING000004955.94
806CALCOCO1/TBC1D5 ratioGCST903136105.93
807Rubneribacter sp002159915 abundance in stoolGCST900325415.92
808T1 FreeSurfer aseg lhCerebralWhiteMatterVolGCST903841855.91
809VCAM1 levelsGCST904710315.91
810IDP T1 FAST ROIs R postcent gyrusGCST900024845.90
811KLRB1 levelsGCST904697095.90
812Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275ECGU0002755.89
813Principal component-derived dietary pattern 4GCST901330095.89
814Red blood cell countGCST902786415.89
815FLT3 levelsGCST904692515.88
816NPTXR levelsGCST904700805.88
817CD244 levelsGCST902747715.87
818eosinophil (absolute count, mean, inv-norm transformed)GCST904752915.87
819Lymphocyte percentage | Blood countUKBB000004125.87
820F-sweetened coffee drink liking (derived food-liking factor)GCST900948535.86
821CD200/CLEC4G ratioGCST903137465.86
822Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB000000835.85
823wg lh intensity-contrast lingualGCST900038045.85
824CTSC levelsGCST904689095.84
825aparc-a2009s lh volume G-front-inf-OpercularGCST900029365.84
826Cervicalgia (PheCode 761)GCST904762675.83
827Beans likingGCST900946995.83
828CHRDL1 levelsGCST904687505.83
829C1QL2 levelsGCST904684875.82
830Neutrophill percentage (UKB data field 30200)GCST904680935.82
831Triacylglycerol_52:3_[M+NH4]1+ levelsGCST900605095.82
832Frailty indexGCST900200535.81
833FABP1/SULT2A1 ratioGCST903147555.79
834ATP5IF1/FXN ratioGCST903133865.78
835Triacylglycerol_51:3_[M+NH4]1+ levelsGCST900604945.78
836CXCL10 levelsGCST902747805.78
837LAIR2 levelsGCST904697295.77
838HippSubfield lh volume CA4-bodyGCST900026835.77
839Chronic iridocyclitisFING000002875.77
840Oral glucose tolerance test-1hGCST905664225.76
841T1 FreeSurfer aseg Left-CaudateGCST903841445.76
842C36:4 Phosphatidylethanolamine levels in chronic kidney diseaseGCST902573575.76
843Friendships satisfaction | Mental healthUKBB000002735.75
844PolyarthropathiesFING000011805.75
845GHRL levelsGCST904693415.74
846CRTAM/GZMA ratioGCST903142755.74
847COLEC12/TAFA5 ratioGCST903141855.74
848Nonspecific chest pain | circulatory systemUKBB000005275.73
849lymphocyte (fraction, minimum, inv-norm transformed)GCST904754385.73
850DTI autoptx FA ptr l tractGCST903851315.70
851DTI autoptx L1 cst l tractGCST903851475.70
852CCN2/VEGFC ratioGCST903137195.69
853CC2D1A/CRADD ratioGCST903136635.68
854Asthma-related infectionsFING000001185.68
855AZU1/CEACAM8 ratioGCST903134245.66
856FGF21 levelsGCST902747885.65
857VAMP5 levelsGCST904710245.65
858FOLH1 levelsGCST904256615.63
859Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST904352035.62
860eosinophil (fraction, minimum, inv-norm transformed)GCST904753035.62
861CDKN1A/TXLNA ratioGCST903139795.61
862IGDCC4 levelsGCST904695235.61
863ADH4/KYNU ratioGCST903131935.60
864Coffee type - Ground coffee (include espresso, filter etc) | DietUKBB000001405.60
865IDP dMRI TBSS MO Posterior limb of internal capsule LGCST900039715.60
866Tryptophan betaine levelsGCST901998195.58
867CD28 levelsGCST904686165.56
868MNDA levelsGCST904699275.56
869Mean reticulocyte volume (UKB data field 30260)GCST904680885.56
870Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283ECGU0002835.56
871HayfeverGCST904681315.56
872IDP dMRI TBSS MO Cerebral peduncle LGCST900039675.55
873Psoriasis and related disorder (PheCode 696)GCST904761865.54
874Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755935.54
875Crohn's diseaseGCST904467935.53
876LGALS3BP levelsGCST904697605.52
877Average total household income before tax | HouseholdUKBB000000815.51
878Spherical power (left) | AutorefractionUKBB000007905.51
879NFASC levelsGCST904700315.50
880aparc-a2009s lh volume S-circular-insula-supGCST900029735.50
881Congestive heart failure; nonhypertensive (PheCode 428)GCST904759815.49
882UCMA levelsGCST902432855.49
883T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903206845.49
884Vitamin and mineral supplements - Multivitamins +/- minerals | MedicationUKBB000009005.49
885Rheumatoid arthritis (PheCode 714.1)GCST904762305.48
886Age high blood pressure diagnosed | Medical conditionsUKBB000000165.48
887Ptosis of eyelidFING000012275.46
888Chicken likingGCST900947325.45
889Biological Mother: Coronary Artery / Coronary Heart DiseaseGCST904754885.44
890Principal component-derived dietary pattern 1GCST901330065.42
891F-wine liking (derived food-liking factor)GCST900948725.42
892SLC4A1 levelsGCST904706635.41
893Conditional arithmetic | Fluid intelligence / reasoningUKBB000001455.41
894FOXO1/USP8 ratioGCST903148795.41
895PSAP levelsGCST904703515.41
896Fracture of upper limb (PheCode 803)GCST904762795.41
897Lymphocyte percentage of white cellsGCST0046325.39
898Mean reticulocyte volumeGCST900023965.39
899CTSZ/HSPG2 ratioGCST903143185.38
900Testosterone | Blood biochemistryUKBB000008165.38
901Psoriasis vulgarisFING000012245.38
902CLEC4G/NELL2 ratioGCST903141225.37
903Time spent watching television (TV) | Physical activityUKBB000008215.37
904DTI TBSS FA Posterior thalamic radiation LGCST903844095.36
905TNF/TNFRSF1B ratioGCST903159425.35
906COL9A1 levelsGCST904688225.35
907CD93/CLEC14A ratioGCST903139215.35
908Chronic obstructive pulmonary disease in ever smokersGCST900165885.34
909CXCL5/SERPINE1 ratioGCST903143545.34
910Right ventricular end systolic volumeGCST901345895.33
911FOXO1/MAP4K5 ratioGCST903148725.33
912Omega-6 fatty acid levelsGCST905025195.32
913IL12RB1 levelsGCST904695505.32
914Recent worrying too much about different things | AnxietyUKBB000007465.31
915AsthmaGCST904681125.31
916FKBP7 levelsGCST904692455.31
917T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903206655.30
918Estradiol levelsGCST900200915.30
919Neutrophill percentage | Blood countUKBB000004985.30
920MED18/TACC3 ratioGCST903154145.30
921Dementia due to Parkinson's disease (more control exclusions)FING000003925.30
922ARHGAP25/RNF41 ratioGCST903133455.30
923Depression or dysthymiaFING000004005.29
924SUOX levelsGCST904707855.29
925Rotator cuff syndromeFING000012705.29
926mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST904754425.29
927TIMD4 levelsGCST904708665.28
928aseg rh intensity Cerebellum-CortexGCST900037815.28
929Maximum digits remembered correctly | Numeric memoryUKBB000004305.28
930ALCAM/LRRC25 ratioGCST903132395.27
931ITGB1BP2/USP8 ratioGCST903152235.26
932Occupation and workplace environment (confirmatory factor analysis Factor 5)GCST903093405.26
933RNASET2 levelsGCST904704815.26
934C1QA levelsGCST904684855.26
935Left-hemisphere control network to caudate white-matter structural connectivityGCST903027535.26
936CD244 levelsGCST904686115.25
937BA-exvivo rh area perirhinalGCST900032335.24
938Retinal vascular disordersFING000012625.24
939T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903206105.24
940Left ventricular end diastolic massGCST902681235.23
941Autoimmune diseases excluding thyroid diseasesFING000001325.23
942BA-exvivo rh area BA6GCST900032275.22
943CCNE1 levelsGCST904685935.22
944Dried fruit intake | DietUKBB000001935.22
945Other joint disordersFING000010645.21
946Inflammatory bowel diseaseGCST904321825.21
947eosinophil (absolute count, maximum, inv-norm transformed)GCST904752885.21
948LCN2/RETN ratioGCST903153085.20
949Second line medication for Crohn's diseaseFING000012845.18
950GYS1/PPP1R2 ratioGCST903150015.18
951Diabetes (weighted GWA)GCST902672795.18
952Other systemic involvement of connective tissue (FG)FING000011165.17
953BLVRB/CA1 ratioGCST903135215.17
954MPHOSPH8/USP8 ratioGCST903154795.17
955Other/unspecified rheumatoid arthritisFING000011265.16
956CCR2 on CD14+ CD16- monocyteGCST900020045.15
957HippSubfield rh volume CA4-bodyGCST900027055.15
958CASP8/DDX58 ratioGCST903136515.14
959ITGB2 levelsGCST904696445.14
960Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004465.14
961MAP3K5/ZBTB16 ratioGCST903153805.13
962T1 CAT volume L LateralOccipitalCortexinferiordivisionGCST903840445.13
963Adhesive capsulitis of shoulderFING000000435.12
964Skin cancerGCST904751895.12
965T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90)GCST903209095.11
966Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759845.11
967SH2D1A levelsGCST904706175.10
968GOLM2/ITGA5 ratioGCST903149515.10
969BSG/LY9 ratioGCST903135345.10
970Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB000001005.09
971Working memoryGCST905031165.08
972Body fat percentage (adjusted for testosterone and SHBG) x sex interactionGCST904321815.08
973ICAM3/SLAMF7 ratioGCST903151235.07
974FCRL5/MZB1 ratioGCST903148045.07
975Principal component-derived dietary pattern 29GCST901330345.06
976Pain type(s) experienced in last month - Stomach or abdominal pain | PainUKBB000006335.06
977neutrophil (fraction, minimum, inv-norm transformed)GCST904755415.05
978CXCL9 levelsGCST904689355.04
979Leisure/social activities - None of the above | Social supportUKBB000003995.04
980CALCOCO1/TJAP1 ratioGCST903136115.03
981Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900254365.03
982Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485ECGA0004855.03
983Erythematosquamous dermatosis (PheCode 690)GCST904761705.02
984Total testosterone levelsGCST900121145.02
985PDCD1 levelsGCST904701815.01
986ADAM12 levelsGCST904682165.00
987Physical activity (Total log acceleration 6pm-8pm)GCST900614185.00
988Mean corpuscular hemoglobin concentrationGCST900023295.00
989Triglyceride levels in very large HDLGCST901326365.00
990Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005724.99
991Age at onset of walkingGCST906510784.99
992Volume of right cortical nucleusGCST904750334.99
993Pollen allergyFING000011764.98
994aparc-DKTatlas rh volume postcentralGCST900029134.98
995Shortness of breath (PheCode 512.7)GCST904760404.98
996Other and unspecified rosaceaFING000009514.98
997Medical abortionFING000007964.96
998CXCL17/LAMP3 ratioGCST903143404.96
999Spirits likingGCST900948484.96
1000Alcohol consumption (drinks per month) (UKB data field 1578, 4424)GCST901329924.95